Concepedia

Hiroyoshi Nishikawa

HN

Statistics

Publications

140

Citations

19.3K

H-Index

56

Active since

2001

Affiliations

Nagoya University(Current)

National Cancer Center Hospital East

The University of Osaka

Chiba Cancer Center

Mie University

Hiroyoshi Nishikawa is an author at Nagoya University specializing in immunology, oncology, and cancer immunotherapy.

Publications per year

2001–2025

140

Publications

140

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

Koji Atarashi, Takeshi Tanoue, Kenshiro Oshima et al. · Nature · 2013 · 2.9K citations

Life Sciences, Immunology, Microbiology +9

Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

Eiichi Sato, Sara H. Olson, Jiyoung Ahn et al. · Proceedings of the National Academy of Sciences · 2005 · 2.4K citations · Full text

Life Sciences, Immunology, Oncology +17

PD-1 <sup>+</sup> regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer

Takahiro Kamada, Yosuke Togashi, Christopher Tay et al. · Proceedings of the National Academy of Sciences · 2019 · 1K citations · Full text

Life Sciences, Immunology, Oncology +17

Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)

Shota Fukuoka, Hiroki Hara, Naoki Takahashi et al. · Journal of Clinical Oncology · 2020 · 926 citations · Full text

Medicine, Oncology, Pharmacology +17

Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Takuro Saito, Hiroyoshi Nishikawa, Hisashi Wada et al. · Nature Medicine · 2016 · 885 citations

Medicine, Immunology, Oncology +12

1–5 of 140